LAM Therapeutics Announces Progress of its Clinical Portfolio with FDA Clearance of New Trial in Leukemia and Advancement of Clinical Trial in Lymphoma GUILFORD, Conn., Nov. 30, 2017 (GLOBE NEWSWIRE) -- LAM Therapeutics (LAM), a 4Catalyzer company, advanced its clinical portfolio with the U.S. Food and Drug Administration (FDA) clearance of LAM’s...

Butterfly Network Announces Over $100M in Financing to Bring Together Novel Devices, Deep Learning and Cloud Computing to Transform Medicine SAN FRANCISCO, CALIF., Nov. 3, 2014 (GLOBE NEWSWIRE) -- 4Combinator, a healthcare startup incubator, announced today that its first company, Butterfly Network, has raised over $100 million to...